Understanding failure in targeted breast cancer therapy
21 Jul 2015
Understanding failure in targeted breast cancer therapy
De-activating chromosomes to prevent cancer
From stem cell to cancer stem cell
Novel strategy could help overcome resistance to radiotherapy in metastatic melanoma
Interim WINTHER study findings provide lessons for future research
WIN Symposium 2015 highlights
Next generation of trials with targeted agents
Meta-analysis confirms benefits and safety of precision medicine
SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC
TAT 2016: Targeted anticancer therapies
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Exciting new developments in proton therapy treatments